Background Benzodiazepine misuse is a growing public health problem, with increases in
benzodiazepine-related overdose deaths and emergency room visits in recent years …

The first hypnotic barbiturate, barbital, was introduced into clinical practice in 1903, followed
by phenobarbital in 1912. 1 In subsequent years, multiple barbiturates were synthesized …

Importance The use of benzodiazepines or alcohol together with opioids increases
overdose risk, but characterization of co-involvement by predominant opioid subtype is …

Background Novel public health interventions are being considered to address the opioid
overdose epidemic, including drug checking technologies. We examined the willingness to …

Introduction Recent research has begun to explore the transition from nonmedical use of
prescription opioids (POs) to heroin and injection drug use, adding to earlier literature …

Background Non-prescribed benzodiazepine use is increasing in North America, especially
among youth. Owing to increasing demand, counterfeit benzodiazepine tablets are mass …

Purpose This qualitative narrative synthesis sought to identify pathways connecting
socioeconomic marginalization (SEM) and overdose for people who use drugs. Methods We …

Bromazolam is a designer benzodiazepine that was first detected in British Columbia in
January 2021. Postmortem cases were analyzed using a comprehensive blood drug …

Objective Opioid withdrawal symptoms are widely understood to contribute to health risk but
have rarely been measured in community samples of opioid using people who inject drugs …

Objective: Persons with opioid use disorder who take benzodiazepines are at high risk for
overdose. The objective of this study was to evaluate the association of benzodiazepine and …